Efficient induction of neural progenitor cells from human ESC/iPSCs on Type I Collagen.

Sci China Life Sci

CAS Key Laboratory of Regenerative Biology, Guangdong Provincial Key Laboratory of Stem Cell and Regenerative Medicine, Guangzhou Institutes of Biomedicine and Health, Chinese Academy of Sciences, Guangzhou, 510530, China.

Published: December 2021

AI Article Synopsis

  • A new method has been developed for efficiently and reliably converting human embryonic stem cells (ESCs) and induced pluripotent stem cells (iPSCs) into neural progenitor cells (NPCs) using Type I Collagen.
  • The differentiated NPCs display essential characteristics and functionality, resembling classic NPCs in lab tests and when tested in a brain injury model, where they help promote healing.
  • The research highlights the role of SMAD signaling and changes in gene expression and chromatin structure during differentiation, making it easier to generate NPCs for potential treatments of neurological disorders.

Article Abstract

A stable, rapid and effective neural differentiation method is essential for the clinical applications of human embryonic stem cells (ESCs) or induced pluripotent stem cells (iPSCs) in treating neurological disorders and diseases. Herein, we established a novel and robust monolayer differentiation method to produce functional neural progenitor cells (NPCs) from human ESC/iPSCs on Type I Collagen. The derived cells not only displayed the requisite markers, but also behaved similarly to classic NPCs both in vitro and in vivo. Upon transplantation into traumatic brain injury model, the derived NPCs facilitated recovery from injury. We also found that SMAD signaling stayed down throughout the differentiation process on Type I Collagen, and the pluripotent signals were rapidly downregulated along with raising up of neural early markers on the third day. Meanwhile, ATAC-seq data showed the related mediation of distinct transcriptome and global chromatin dynamics during NPC induction. Totally, our results thus provide a convenient way to generate NPCs from human ESC/iPSCs for neural diseases' treatment.

Download full-text PDF

Source
http://dx.doi.org/10.1007/s11427-020-1897-0DOI Listing

Publication Analysis

Top Keywords

human esc/ipscs
12
type collagen
12
neural progenitor
8
progenitor cells
8
esc/ipscs type
8
differentiation method
8
stem cells
8
npcs human
8
neural
5
cells
5

Similar Publications

Efficient induction of neural progenitor cells from human ESC/iPSCs on Type I Collagen.

Sci China Life Sci

December 2021

CAS Key Laboratory of Regenerative Biology, Guangdong Provincial Key Laboratory of Stem Cell and Regenerative Medicine, Guangzhou Institutes of Biomedicine and Health, Chinese Academy of Sciences, Guangzhou, 510530, China.

Article Synopsis
  • A new method has been developed for efficiently and reliably converting human embryonic stem cells (ESCs) and induced pluripotent stem cells (iPSCs) into neural progenitor cells (NPCs) using Type I Collagen.
  • The differentiated NPCs display essential characteristics and functionality, resembling classic NPCs in lab tests and when tested in a brain injury model, where they help promote healing.
  • The research highlights the role of SMAD signaling and changes in gene expression and chromatin structure during differentiation, making it easier to generate NPCs for potential treatments of neurological disorders.
View Article and Find Full Text PDF

Pluripotent stem cell for modeling neurological diseases.

Exp Cell Res

January 2013

Department of Surgery, Development and Growth, Li Ka Shing Faculty of Medicine, University of Hong Kong, Pokfulam, Hong Kong.

The availability of human pluriopotent stem cells, embryonic (ESC) and induced pluriopotent (iPSC) stem cells, not only can be a renewable source for investigating the early human development, etiology and progression of different diseases but also recapitulating the disease with the same genomic materials of the patient. In particular, specific neuronal subtypes generated from the patient ESC/iPSCs has become a source for studying disease mechanisms underlying different neurological disorders and allowed drug discovery. In this review, we summarize the recent advances in establishing patient ESC/iPSC to model various neurological diseases.

View Article and Find Full Text PDF

Embryonic stem cells (ESCs) are an attractive source for tissue regeneration and repair therapies because they can be differentiated into virtually any cell type in the adult body. However, for this approach to succeed, the transplanted ESCs must survive long enough to generate a therapeutic benefit. A major obstacle facing the engraftment of ESCs is transplant rejection by the immune system.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!